BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32811775)

  • 1. Cardiovascular risk and validation of cardiovascular risk prediction functions in a cohort of patients with type 2 diabetes followed for 10 years in Badajoz (SPAIN). AN observational study.
    Calvo-Hueros JI; Cañón-Barroso L; Morales-Gabardino JA; Buitrago F
    Prim Care Diabetes; 2021 Feb; 15(1):115-120. PubMed ID: 32811775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Original and REGICOR Framingham functions in a nondiabetic population of a Spanish health care center: a validation study.
    Buitrago F; Calvo-Hueros JI; Cañón-Barroso L; Pozuelos-Estrada G; Molina-Martínez L; Espigares-Arroyo M; Galán-González JA; Lillo-Bravo FJ
    Ann Fam Med; 2011; 9(5):431-8. PubMed ID: 21911762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic kidney disease prevalence and cardiovascular risk in a cohort of patients with type 2 diabetes followed for 10 years in Badajoz (Spain). An observational study.
    Calvo-Hueros JI; Martín-Hidalgo-Barquero MV; Morales-Gabardino JA; Buitrago F
    Prim Care Diabetes; 2021 Apr; 15(2):391-396. PubMed ID: 33323354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Validation of 3 equations of coronary risk in diabetic population of a primary care center].
    Cañón-Barroso L; Cruces-Muro E; Fernández-Ochoa G; Nieto-Hernández T; García-Vellido A; Buitrago F
    Med Clin (Barc); 2006 Apr; 126(13):485-90. PubMed ID: 16624226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Predictive capacity, comparison and clinic consequences of the Framingham-Wilson and REGICOR tables in persons for whom care has been provided at a health care center, Badajoz, Spain].
    Cañón Barroso L; Díaz Herrera N; Cruces Muro E; Nieto Hernández T; Garrote Florencio T; Buitrago F
    Rev Esp Salud Publica; 2007; 81(4):353-64. PubMed ID: 18041538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Framingham function overestimates the risk of ischemic heart disease in HIV-infected patients from Barcelona.
    Herrera S; Guelar A; Sorlì L; Vila J; Molas E; Grau M; Marrugat J; Esteve E; Güerri-Fernández R; Montero M; Knobel H
    HIV Clin Trials; 2016 Jul; 17(4):131-9. PubMed ID: 27169692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the Framingham and SCORE cardiovascular risk prediction functions in a non-diabetic population of a Spanish health care centre: a validation study.
    Barroso LC; Muro EC; Herrera ND; Ochoa GF; Hueros JI; Buitrago F
    Scand J Prim Health Care; 2010 Dec; 28(4):242-8. PubMed ID: 20873973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of the SCORE function chart and the Framingham-REGICOR equation to estimate the cardiovascular risk in an urban population after 10 years of follow-up].
    Buitrago Ramírez F; Cañón Barroso L; Díaz Herrera N; Cruces Muro E; Bravo Simón B; Pérez Sánchez I
    Med Clin (Barc); 2006 Sep; 127(10):368-73. PubMed ID: 16987481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Incidence of cardiovascular disease and validity of equations of coronary risk in diabetic patients with metabolic syndrome].
    Cañón Barroso L; Díaz Herrera N; Calvo Hueros JI; Cruces Muro E; Nieto Hernández T; Buitrago Ramírez F
    Med Clin (Barc); 2007 Apr; 128(14):529-35. PubMed ID: 17433206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of the SCORE and REGICOR models for calculating cardiovascular risk in cardiovascular disease-free individuals at a healthcare center in Barcelona, Spain].
    Baena Díez JM; del Val Garcia JL; Héctor Salas Gaetgens L; Sánchez Pérez R; Altes Vaques E; Deixens Martínez B; Amatller Corominas M; Katia Núñez Casillas D
    Rev Esp Salud Publica; 2005; 79(4):453-64. PubMed ID: 16465962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiovascular risk in diabetes mellitus and hypertension in Spain. The CORONARIA study].
    Cosín Aguilar J; Rodríguez Padial L; Hernándiz Martínez A; Arístegui Urrestarazu R; Masramón Morell X; Armada Peláez B; Aguilar Llopis A; Zamorano Gómez JL
    Med Clin (Barc); 2006 Jun; 127(4):126-32. PubMed ID: 16831392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derivation and validation of a set of 10-year cardiovascular risk predictive functions in Spain: the FRESCO Study.
    Marrugat J; Subirana I; Ramos R; Vila J; Marín-Ibañez A; Guembe MJ; Rigo F; Tormo Díaz MJ; Moreno-Iribas C; Cabré JJ; Segura A; Baena-Díez JM; de la Cámara AG; Lapetra J; Grau M; Quesada M; Medrano MJ; González Diego P; Frontera G; Gavrila D; Aicua EA; Basora J; García JM; García-Lareo M; Gutierrez JA; Mayoral E; Sala J; D'Agostino R; Elosua R;
    Prev Med; 2014 Apr; 61():66-74. PubMed ID: 24412897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The REGICOR-calibrated function provides a better classification of high-risk patients on statin treatment in the Spanish population than the Framingham or SCORE classifications.
    Baena-Díez JM; Grau M; Sánchez-Pérez R; Altes-Vaques E; Salas-Gaetjens LH; Hernández-Ibáñez MR
    Rev Esp Cardiol; 2009 Oct; 62(10):1134-40. PubMed ID: 19793519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study.
    Collins GS; Altman DG
    BMJ; 2009 Jul; 339():b2584. PubMed ID: 19584409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Estimating cardiovascular risk in Spain using different algorithms].
    Comín E; Solanas P; Cabezas C; Subirana I; Ramos R; Gené-Badía J; Cordón F; Grau M; Cabré-Vila JJ; Marrugat J
    Rev Esp Cardiol; 2007 Jul; 60(7):693-702. PubMed ID: 17663853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiovascular risk in patients with renal failure].
    Calvo Hueros JI; Cañón Barroso L; Gómez Jiménez C; Martín Hidalgo-Barquero MV; Espigares Arroyo M; Buitrago Ramírez F
    Med Clin (Barc); 2008 Jun; 131(2):41-6. PubMed ID: 18588827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relative validity of the 10-year cardiovascular risk estimate in a population cohort of the REGICOR study].
    Marrugat J; Vila J; Baena-Díez JM; Grau M; Sala J; Ramos R; Subirana I; Fitó M; Elosua R
    Rev Esp Cardiol; 2011 May; 64(5):385-94. PubMed ID: 21482004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adding low ankle brachial index to classical risk factors improves the prediction of major cardiovascular events. The REGICOR study.
    Velescu A; Clara A; Peñafiel J; Ramos R; Marti R; Grau M; Dégano IR; Marrugat J; Elosua R;
    Atherosclerosis; 2015 Aug; 241(2):357-63. PubMed ID: 26071658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study.
    Liu J; Hong Y; D'Agostino RB; Wu Z; Wang W; Sun J; Wilson PW; Kannel WB; Zhao D
    JAMA; 2004 Jun; 291(21):2591-9. PubMed ID: 15173150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of population coronary heart disease risk estimated by the Framingham original and REGICOR calibrated functions].
    Ramos R; Solanas P; Cordón F; Rohlfs I; Elosua R; Sala J; Masiá R; Faixedas MT; Marrugat J
    Med Clin (Barc); 2003 Oct; 121(14):521-6. PubMed ID: 14599406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.